FMBH First Mid posts Q1 2026 earnings five percent above analyst estimates shares edge modestly higher FBIN Fortune posts 154 Q4 2025 EPS miss prompting a 258 drop in its share price during todays session CMIIW Columbus Cap outlines forwardlooking strategic growth plans as latest quarterly earnings metrics remain undisclosed Communication Services Select Sector SPDR XLC Outperforms SP 500 Sectors Amid PreCatalyst Market Caution Raspberry Pi Chief Warns AI Fears May Deter Young Talent from Tech Careers Risking Economic Growth Trump Exclusive Iran Conflict Could Delay Interest Rate Plans Intel Stake Regret Revealed Leapmotor Targets German Market with 57 Monthly EV Lease A New Price War in Europe Bronstein Gewirtz Grossman LLC Alleges Investor Harm Class Action Filed Against Babcock Wilcox Enterprises Plus500 Reports 11 Quarterly Revenue Increase Reaffirms Market Expectations Britannia Stock Shows Mixed Signals Amid Market Volatility Tesla Launches Full SelfDriving Supervised in China Amid Surge of Domestic EV Competition NTPC Q4 Profit Surges 34 YoY to Rs 10615 Crore Board Declares Rs 35Share Dividend Movado Group Files Quarterly 10Q Report Market Awaits Financial Details Panchamrutha Industries Unveils Fortified Rice with Essential Vitamins and Minerals in Bengaluru Live Ventures Q1 2026 Earnings Positive EPS Reported Amid Limited Disclosure ADBE Q1 2026 Earnings EPS Tops Estimates Slightly Stock Edges Higher TransCode Therapeutics Q4 2024 Earnings WiderthanExpected Loss Reflects ClinicalStage Investment Warby Parker WRBY Q1 2026 Earnings EPS Beats Estimates by 155 Stock Gains LUMN Q1 2026 Earnings Significant EPS Miss as Company Faces Ongoing Challenges Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage Andretti Acquisition Corp II POLE Holds Steady Near Trust Value Amid Minimal Volatility Leapfrog Acquisition Corporation LFAC Holds Steady at 998 Key Levels in Focus Santacruz Silver Mining SCZM Slides 244 as Silver Market Weakness Pressures Shares Silexion Therapeutics SLXN Slips 3 as Shares Test Key Support at 040 Starry Sea Acquisition Corp Rights SSEAR Holds Steady at 017 Amid Thin Trading Meta Plans 6065 Billion Capital Spending Surge for AI Massive Data Center OMC Q1 2026 Earnings EPS Surpasses Estimates Amid Mixed Market Dynamics UroGen Pharma URGN Advances 197 Approaching Key Resistance at 3093